DADC
BLU

D.A. Davidson & Co’s BELLUS Health Inc. BLU Stock Holding History

D.A. Davidson & Co’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-125,170
Closed -$389K – 1248
2021
Q2 		$389K Sell
125,170
-45,730
-27% -$175K ﹤0.01% 907
2021
Q1 		$656K Buy
170,900
+132,800
+349% +$504K 0.01% 715
2020
Q4 		$117K Buy
+38,100
New +$103K ﹤0.01% 987

Other funds holding BLU

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

D.A. Davidson & Co's BLU Position: Q3 2021 in Review

D.A. Davidson & Co sold out of BELLUS Health Inc. (BLU) in Q3 2021, closing a stake of 125,170 shares — an estimated $389K sold.

D.A. Davidson & Co first reported a position in BLU in Q4 2020 and held it in 3 quarters. The position peaked at $656K in Q1 2021. 55 funds tracked by Wall St. Rank hold BLU as of Q3 2021.

  • D.A. Davidson & Co reported no remaining BELLUS Health Inc. position as of Q3 2021 after selling out during the quarter.
  • D.A. Davidson & Co sold 125,170 BELLUS Health Inc. shares in Q3 2021, an estimated $389K.
  • D.A. Davidson & Co first reported a position in BELLUS Health Inc. in Q4 2020 and held it in 3 quarters.
  • D.A. Davidson & Co's BELLUS Health Inc. position peaked at $656K in Q1 2021.
  • 55 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q3 2021.

Based on D.A. Davidson & Co's 13F filing for Q3 2021, filed 15 Nov 2021.